Skip to main navigation Skip to search Skip to main content

Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article numbere564
JournalClinical and Translational Medicine
Volume11
Issue number11
DOIs
Publication statusPublished - Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this